Petros Pharmaceuticals's market cap is currently $1.50M. The company's EPS TTM is $-6.205; its P/E ratio is ―; Petros Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 5.82M	$ 5.99M	$ 7.81M	$ 9.56M	$ 15.58M
Gross Profit	$ 4.19M	$ 3.70M	$ 6.21M	$ 5.51M	$ 8.15M
Operating Income	$ -13.62M	$ -15.85M	$ -18.05M	$ -17.28M	$ -16.87M
EBITDA	$ -4.21M	$ -13.73M	$ -1.64M	$ -12.21M	$ -14.00M
Net Income	$ -8.16M	$ -27.04M	$ -9.36M	$ -20.59M	$ -32.51M
Balance Sheet
Cash & Short-Term Investments	$ 13.34M	$ 9.43M	$ 23.85M	$ 17.14M	$ 2.15M
Total Assets	$ 33.80M	$ 32.42M	$ 67.39M	$ 69.85M	$ 58.37M
Total Debt	$ 8.28M	$ 9.74M	$ 405.02K	$ 7.18M	$ 13.74M
Net Debt	$ -5.06M	$ 314.19K	$ -23.44M	$ -9.96M	$ 11.60M
Total Liabilities	$ 21.32M	$ 15.72M	$ 31.85M	$ 52.38M	$ 50.35M
Stockholders' Equity	$ 12.48M	$ 16.70M	$ 35.54M	$ 17.47M	$ 8.02M
Cash Flow
Free Cash Flow	$ -7.63M	$ -12.80M	$ -11.86M	$ -15.31M	$ 2.46M
Operating Cash Flow	$ -7.63M	$ -12.80M	$ -11.86M	$ -15.31M	$ 2.53M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ -4.63K	$ -71.54K
Financing Cash Flow	$ 11.54M	$ -1.62M	$ 18.57M	$ 30.30M	$ -3.11M

Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

Income Statement >

Petros Pharmaceuticals Debt to Assets

Balance Sheet >

Petros Pharmaceuticals Cash Flow

Cash Flow >

Petros Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing